Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 19Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer Metastatic 1NSCLC Harboring NRG1 Fusion 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Castrate-resistant Prostate Cancer 1Adenocarcinoma 1

Interventions

enzalutamide 2cabazitaxel 1Prednisone 1Positron Emission Tomography Computed Tomography 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Prostate Cancer Metastatic × Abiraterone Acetate × Clear all
NCT02379390 2019-06-21

PRIMCAB

Sanofi

Phase 2 Terminated
8 enrolled 8 charts
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡